Recruiting studies: Crc

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Electrolyte Beverage Combined With Polyethylene Glycol for Colonoscopy Bowel Preparation
NA · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT07608120 AI-Assisted Non-Contrast CT for Multi-Cancer Screening
NA · 1 location(s) · Guo ShiWei · NCT06632886 Short-term and Long-term Outcomes of Colorectal Cancer Treated With Natural Orifice Specimen Extraction Surgery : a Nati
NA · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06350370 Ventral Hernias Following Cytoreductive Surgery : Incidence, Risk Factors and Surgical Management.
Phase N/A · 1 location(s) · Jules Bordet Institute · NCT07451483 Open-label Phase 2 Study of Avutometinib (RAF/MEK Clamp) in Combination With Defactinib (FAK Inhibitor) and Cetuximab in
Phase 2 · 1 location(s) · M.D. Anderson Cancer Center · NCT06369259 Comparing Chidamide+Sintilimab+Bev With Standard Second-line FOLFIRI+Bev in Advanced MSS/pMMR mCRC
Phase 3 · 12 location(s) · Sun Yat-sen University · NCT05768503 Blood Clearance Kinetics of the Nucleosome and CTCF in Peritoneal Metastasis Colorectal Cancer.
NA · 1 location(s) · Hospices Civils de Lyon · NCT06929013 ctDNA in CRC Patients Undergoing Curative-intent Surgery for Liver Metastases
Phase N/A · 16 location(s) · GERCOR - Multidisciplinary Oncology Cooperative Group · NCT05787197 Personalized Health Self-Management Training for Colorectal Cancer Survivors
NA · 2 location(s) · University of Southern California · NCT05984589 Thalidomide Enhances Clinical Efficacy of Cetuximab Combined With Standard Chemotherapy for Left Colorectal Cancer
Phase 2 · 1 location(s) · Xinqiao Hospital of Chongqing · NCT06279351 Sequential TAS-OX Alternating With TAS-IRI Plus Bevacizumab for Late-Line Metastatic Colorectal Cancer
Phase 2 · 9 location(s) · Rutgers, The State University of New Jersey · NCT05806931 Upfront Trastuzumab-Deruxtecan Plus Capecitabine and Bevacizumab for Patients With HER-2 Positive Metastatic Colorectal
Phase 2 · 28 location(s) · Gruppo Oncologico del Nord-Ovest · NCT07407465 A Study to Learn About the Study Medicine Called PF-07799933 in People With Advanced Solid Tumors With BRAF Alterations.
Phase 1 · 40 location(s) · Pfizer · NCT05355701 A Noninvasive and Screening miRNA Signature for Gastrointestinal Cancer
Phase N/A · 1 location(s) · City of Hope Medical Center · NCT07224750 A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Te
Phase 2 · 48 location(s) · AbbVie · NCT07023289 A Multi-center Investigation of Family Health.
Phase N/A · 1 location(s) · Odense University Hospital · NCT06433349 RESPONSE: Colorectal Cancer Survivors' Follow-up Care - Now Digital and Need-based
NA · 9 location(s) · University of Aarhus · NCT06614647 Clinical Trial of an Anti-cancer Drug, CA-4948 (Emavusertib), in Combination With Chemotherapy Treatment (FOLFOX Plus Be
Phase 1 · 13 location(s) · National Cancer Institute (NCI) · NCT06696768 Regorafenib Alone or in Combination With Hypofractionated/Low-dose Radiotherapy Plus Toripalimab for Metastatic Colorect
Phase 2 · 1 location(s) · Fudan University · NCT05963490 Liposomal Irinotecan (II) Fractionated Dosing Combined With 5-FU/LV (FOLFIRInali-3) and Bevacizumab in Second-line Treat
Phase 2 · 1 location(s) · Tianjin Medical University Cancer Institute and Hospital · NCT07047560 AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer
Phase 3 · 2 location(s) · Akeso · NCT06951503 FOLICOLOR TRIAL: Following Therapy Response Through Liquid Biopsy in Metatstatic Colorectal Cancer Patients
Phase 3 · 9 location(s) · University Hospital, Antwerp · NCT07558083 Development of a cfDNA 5mC/5hmC-based Biomarker Panel to Predict Targeted Therapy Efficacy in mCRC
Phase N/A · 1 location(s) · City of Hope Medical Center · NCT07224841 Comparing 18F-FAPI PET-Guided Abdominal Radiotherapy Combined With Second-Line Standard Therapy and Cadonilimab Versus S
Phase 2 · 2 location(s) · Fudan University · NCT07079462 Institut Paoli Calmettes Colorectal Cancer Database
Phase N/A · 1 location(s) · Institut Paoli-Calmettes · NCT02869503 Phase 1 Study Evaluating the Safety and PK of ADU-1805 in Advanced Solid Tumors
Phase 1 · 7 location(s) · Sairopa B.V. · NCT05856981 Locally ablatIVe thErapy for oLigo-progressive gastrOintestiNal maliGnancies (LIVELONG)
NA · 1 location(s) · University of California, Davis · NCT06101277 AI-Assisted Chemotherapy Side Effect Management
NA · 1 location(s) · Incheon St.Mary's Hospital · NCT07198581 A Study of BMS-986340 as Monotherapy and as Combination Therapy in Participants With Advanced Solid Tumors
Phase 1/Phase 2 · 47 location(s) · Bristol-Myers Squibb · NCT04895709 Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Phase 1 · 8 location(s) · Orano Med Theranostics, SAS · NCT05283330

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.